021-51111890
购物车（）
sales@molnova.cn
hDHODH-IN-1
CAS No. 1173715-42-8
hDHODH-IN-1 ( —— )
产品货号. M26247 CAS No. 1173715-42-8
hDHODH-IN-1 is an inhibitor of human dihydroorotate dehydrogenase (hDHODH) with an anti-inflammatory effect.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥1936 | 有现货 |
|
| 10MG | ￥3102 | 有现货 |
|
| 25MG | ￥5241 | 有现货 |
|
| 50MG | ￥7468 | 有现货 |
|
| 100MG | ￥10125 | 有现货 |
|
| 500MG | ￥20169 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称hDHODH-IN-1
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述hDHODH-IN-1 is an inhibitor of human dihydroorotate dehydrogenase (hDHODH) with an anti-inflammatory effect.
-
产品描述hDHODH-IN-1 is an inhibitor of human dihydroorotate dehydrogenase (hDHODH) with an anti-inflammatory effect.(In Vitro):Dihydroorotate dehydrogenase (DHODH) is a class-2 dihydroorotate dehydrogenase in human.?Inhibitors have been developed to eliminate human DHODH (hDHODH) activity, which is associated with cancers,inflammatory diseases , and autoimmune and multiple sclerosis because DHODH is required to ensure proliferating-cell viability.
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点Dehydrogenase
-
受体PEGs
-
研究领域——
-
适应症——
化学信息
-
CAS Number1173715-42-8
-
分子量278.3
-
分子式C17H14N2O2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC\C(O)=C(/C#N)C(=O)Nc1ccc(cc1)-c1ccccc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
产品手册
关联产品
-
Atovaquone
Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.
-
LDH-IN-1
LDH-IN-1 is a novel pyrazole-based inhibitor of human lactate dehydrogenase (LDH) with IC50s of 32 and 27 nM for LDHA and LDHB, respectively.?LDH-IN-1 inhibits the growth of MiaPaCa2 pancreatic cancer and A673 sarcoma cells with IC50s of 2.23 and 1.21 μM).
-
Dovitinib Dilactic A...
Dovitinib Dilactic acid (TKI258 Dilactic acid) is the Dilactic acid of Dovitinib, which is a multitargeted RTK inhibitor.
